|
| Press Releases |
|
 |
|
| Tuesday, July 12, 2016 |
|
|
A New Way to Diagnose and Treat Lung Cancer |
| A team of researchers from Singapore has discovered a class of small RNA molecules, known as oncomiRs, which are responsible for fuelling lung cancer. more info >> |
|
| Friday, July 8, 2016 |
|
|
A New Way of Looking at Cancer |
| Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have reported that these clusters are unlike what others have assumed previously, potentially opening up new ways to detect and inhibit the spread of cancer. more info >> |
|
| Friday, June 3, 2016 |
|
|
New Material Kills E. Coli Bacteria in 30 Seconds |
| Every day, we are exposed to millions of harmful bacteria that can cause infectious diseases, such as the E. coli bacteria. Now, researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have developed a new material that can kill the E. coli bacteria within 30 seconds. more info >> |
|
| Friday, May 20, 2016 |
|
|
Real-Time Imaging of Embryo Development Could Pave the Way for More Effective Human Reproduction Therapies |
| Researchers at A*STAR's Institute of Molecular and Cell Biology (IMCB) have developed advanced microscopy technologies to monitor embryo development in real time, revealing how mammalian cells differentiate during the earliest stages of embryonic life. more info >> |
|
| Monday, May 16, 2016 |
|
|
Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology |
| Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical company, and the Institute of Molecular and Cell Biology (IMCB), a research institute under the aegis of the Agency for Science, Technology and Research (A*STAR), Singapore, today announced the signature of a research partnership to study the intracellular trafficking of botulinum neurotoxins (BoNTs) within neurons. more info >> |
|
| Friday, May 13, 2016 |
|
|
New Technique Paves the Way for Drug Targeting to Fight Microbial Resistance |
| Research investigators in Singapore have developed a new high throughput method that identifies how ribonucleic acid (RNA) molecules come together in an unbiased and large-scale manner inside cells. more info >> |
|
| Wednesday, May 11, 2016 |
|
|
Scientists Discover New Technology Breakthrough in Fighting Viral Diseases |
| Today, IBM Research (NYSE: IBM) and Singapore's Institute of Bioengineering and Nanotechnology (IBN) announced that they have identified a new breakthrough macromolecule that could help prevent deadly virus infections with a unique triple-play mechanism that can also help prevent viral drug resistance. more info >> |
|
| Wednesday, February 3, 2016 |
|
|
A*STAR and US EPA to Co-develop Innovative Methods to Assess and Predict the Safety of Chemicals, without Relying on Animal Testing |
| Singapore's Agency for Science, Technology and Research (A*STAR) and the United States Environmental Protection Agency (EPA) are partnering to develop new approaches to identify chemicals that could pose a risk to human health. more info >> |
|
| Monday, January 25, 2016 |
|
|
International Collaboration to Advance Research on Non-Animal Approaches to Chemical Safety Testing |
| Singapore's Agency for Science, Technology and Research (A*STAR) and the United States Environmental Protection Agency (EPA) are partnering to develop new approaches to identify chemicals that could pose a risk to human health. more info >> |
|
| Friday, November 6, 2015 |
|
|
Scratching the Surface of Skin Disease |
| An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
USDKG launching: $50M Gold-backed Stablecoin in the Kyrgyz Republic 
Nov 29, 2025 23:00 HKT/SGT
|
|
|
Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan
Nov 28, 2025 23:00 JST
|
|
|
Capital Revo Expands Trader Education Framework Amid Rising 2025 User Engagement
Nov 28, 2025 22:00 HKT/SGT
|
|
|
Eternal Beauty Holdings Announces First Results Since Listing, Interim Profit for FY2025/2026 Increased 15.3% YoY to RMB 1.3 Million
Nov 28, 2025 20:12 HKT/SGT
|
|
|
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Nov 28, 2025 19:41 JST
|
|
|
MHI Publishes "MHI REPORT 2025" and "SUSTAINABILITY DATABOOK 2025"
Nov 28, 2025 19:05 JST
|
|
|
Sharp Wins IAM's "Asia IP Elite 2025", Awarded to Companies with Outstanding Intellectual Property Strategy for The Second Consecutive Year
Nov 28, 2025 18:36 JST
|
|
|
Think Business, Think Hong Kong strengthens Italy-Hong Kong ties and opens new path for Asian collaboration
Nov 28, 2025 17:03 HKT/SGT
|
|
|
Fujitsu builds platform for NSK to create environmental value throughout the product lifecycle of bearing products
Nov 28, 2025 18:01 JST
|
|
|
Fujitsu launches Japan Edition of SAP Fioneer Cloud for Insurance, a next-generation platform supporting core business operations in the Japanese insurance industry
Nov 28, 2025 17:28 JST
|
|
|
Edvantage Group Announces FY2025 Annual Results
Nov 28, 2025 13:00 HKT/SGT
|
|
|
Magnolia Welcomes Tech Pioneer Luc Haldimann as New Board Chairman to Expand Global Growth and AI Strategy
Nov 28, 2025 00:00 HKT/SGT
|
|
|
NEC Launches Sales Support Solution Utilizing Agentic AI
Nov 27, 2025 22:31 JST
|
|
|
Fujitsu and Yamaguchi University develop low-power edge computing technology for near real-time image processing on small satellites
Nov 27, 2025 22:00 JST
|
|
|
Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Interim Results
Nov 27, 2025 18:43 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
